Journal of Risk Analysis and Crisis Response

Volume 10, Issue 3, October 2020, Pages 97 - 100

Five Supplementary Therapies for COVID-19

Authors
Li-Yuan Liu*
College of Life Science, Beijing Normal University, China
Corresponding Author
Li-Yuan Liu
Received 23 April 2020, Accepted 9 October 2020, Available Online 2 November 2020.
DOI
https://doi.org/10.2991/jracr.k.201022.001How to use a DOI?
Keywords
COVID-19; therapy; sputum suction; semireclining posture; coldrex; Vitamin B2; SO2; aspirin; dexamethasone
Abstract

The COVID-19 is characteristic of both damage of the respiratory system and the immune system or both similarities of SARS and AIDS. These features decide difficulty of specific treatment. The worldwide transmission and higher fatality rate call for new skills for prevention and treatment. Here, we recommend five supplementary therapies for COVID-19. (1) Discharging viruses from lungs by exhaling, coughing and suction are firstly emphasized. (2) Semireclining posture instead of lying supine for lightening hyperemia and edema of inflammation and dyspnea. (3) Non-steroidal anti-inflammatory coldrex, such as tylenol and paracetamol, can be safely used for controlling inflammation. (4) Vitamin B2 must be used for repairing of mucous membrane of the respiratory tract and as antioxidants. (5) It is most emphasized that sulfur dioxide (SO2) produced from burning sulfur and explosion of firecrackers has a potent antimicrobial effect for air disinfectant and killing viruses in the lungs. In addition to the general therapies, all these methods or therapies can be simply and effectively supplied to patients for discharging viruses, inhibiting viruses and killing viruses, and for recovery from damages.

Copyright
© 2020 The Authors. Published by Atlantis Press B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Journal of Risk Analysis and Crisis Response
Volume-Issue
10 - 3
Pages
97 - 100
Publication Date
2020/11/02
ISSN (Online)
2210-8505
ISSN (Print)
2210-8491
DOI
https://doi.org/10.2991/jracr.k.201022.001How to use a DOI?
Copyright
© 2020 The Authors. Published by Atlantis Press B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - JOUR
AU  - Li-Yuan Liu
PY  - 2020
DA  - 2020/11/02
TI  - Five Supplementary Therapies for COVID-19
JO  - Journal of Risk Analysis and Crisis Response
SP  - 97
EP  - 100
VL  - 10
IS  - 3
SN  - 2210-8505
UR  - https://doi.org/10.2991/jracr.k.201022.001
DO  - https://doi.org/10.2991/jracr.k.201022.001
ID  - Liu2020
ER  -